13 results
8-K
EX-99.1
VRNA
Verona Pharma Plc
9 May 24
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:22am
of phosphodiesterase (“PDE”) in inflammation and lung function impairment in COPD as well as three innovation hub presentations led by clinical experts
DEF 14A
tdv9yup1 r5hvrvt
19 Mar 21
Definitive proxy
4:02pm
10-K
ttya0
25 Feb 21
Annual report
8:29am
F-1/A
354sbxl f785
25 Aug 20
Registration statement (foreign) (amended)
4:06pm
F-1
qviix 8kwto
17 Aug 20
Registration statement (foreign)
6:41am
20-F
voru72pgthud5v
27 Feb 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next